These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 17907813)

  • 1. CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cells.
    Opavsky R; Wang SH; Trikha P; Raval A; Huang Y; Wu YZ; Rodriguez B; Keller B; Liyanarachchi S; Wei G; Davuluri RV; Weinstein M; Felsher D; Ostrowski M; Leone G; Plass C
    PLoS Genet; 2007 Sep; 3(9):1757-69. PubMed ID: 17907813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.
    van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP
    J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies.
    Yu L; Liu C; Bennett K; Wu YZ; Dai Z; Vandeusen J; Opavsky R; Raval A; Trikha P; Rodriguez B; Becknell B; Mao C; Lee S; Davuluri RV; Leone G; Van den Veyver IB; Caligiuri MA; Plass C
    Genomics; 2004 Oct; 84(4):647-60. PubMed ID: 15475242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting aberrant CpG island methylation.
    Feltus FA; Lee EK; Costello JF; Plass C; Vertino PM
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12253-8. PubMed ID: 14519846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
    Esteller M
    Oncogene; 2002 Aug; 21(35):5427-40. PubMed ID: 12154405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer.
    Lujambio A; Portela A; Liz J; Melo SA; Rossi S; Spizzo R; Croce CM; Calin GA; Esteller M
    Oncogene; 2010 Dec; 29(48):6390-401. PubMed ID: 20802525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
    Zhong S; Tang MW; Yeo W; Liu C; Lo YM; Johnson PJ
    Clin Cancer Res; 2002 Apr; 8(4):1087-92. PubMed ID: 11948118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
    Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
    Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG content affects gene silencing in mice: evidence from novel transgenes.
    Chevalier-Mariette C; Henry I; Montfort L; Capgras S; Forlani S; Muschler J; Nicolas JF
    Genome Biol; 2003; 4(9):R53. PubMed ID: 12952532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation patterns suggest the involvement of DNMT3B and TET1 in osteosarcoma development.
    Pires SF; de Barros JS; da Costa SS; de Oliveira Scliar M; Van Helvoort Lengert A; Boldrini É; da Silva SRM; Tasic L; Vidal DO; Krepischi ACV; Maschietto M
    Mol Genet Genomics; 2023 May; 298(3):721-733. PubMed ID: 37020053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of DNA methylation in hematologic malignancies.
    Rush LJ; Plass C
    Cancer Lett; 2002 Nov; 185(1):1-12. PubMed ID: 12142073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential role for Dnmt1 in the prevention and maintenance of MYC-induced T-cell lymphomas.
    Peters SL; Hlady RA; Opavska J; Klinkebiel D; Novakova S; Smith LM; Lewis RE; Karpf AR; Simpson MA; Wu L; Opavsky R
    Mol Cell Biol; 2013 Nov; 33(21):4321-33. PubMed ID: 24001767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
    Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
    J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
    Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
    J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of CpG island loci of multiple tumor suppressor genes in retinoblastoma.
    Cohen Y; Merhavi-Shoham E; Avraham RB; Frenkel S; Pe'er J; Goldenberg-Cohen N
    Exp Eye Res; 2008 Feb; 86(2):201-6. PubMed ID: 18068703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma.
    Alaminos M; Davalos V; Cheung NK; Gerald WL; Esteller M
    J Natl Cancer Inst; 2004 Aug; 96(16):1208-19. PubMed ID: 15316056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
    Lin X; Asgari K; Putzi MJ; Gage WR; Yu X; Cornblatt BS; Kumar A; Piantadosi S; DeWeese TL; De Marzo AM; Nelson WG
    Cancer Res; 2001 Dec; 61(24):8611-6. PubMed ID: 11751372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of SNPs on CpG Islands in the MYC and HRAS oncogenes and in a wide variety of tumor suppressor genes: A multi-cancer approach.
    Samy MD; Yavorski JM; Mauro JA; Blanck G
    Cell Cycle; 2016 Jun; 15(12):1572-8. PubMed ID: 27074591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of epigenetically regulated genes in breast cancer cell lines.
    Loss LA; Sadanandam A; Durinck S; Nautiyal S; Flaucher D; Carlton VE; Moorhead M; Lu Y; Gray JW; Faham M; Spellman P; Parvin B
    BMC Bioinformatics; 2010 Jun; 11():305. PubMed ID: 20525369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.